pfizer - Search News

News

FDA, Pfizer and Covid

FDA may revoke Pfizer COVID-19 vaccine authorization for kids under certain age

The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.

CNBC on MSN · 1d

FDA may pull authorization of Pfizer's Covid vaccine for children under 5, company says

The potential move to rescind authorization of Pfizer's vaccine could leave some kids in the U.S. with no available shots against Covid.

The Hill on MSN · 3h

FDA considers revoking Pfizer COVID vaccine for children under 5

The Food and Drug Administration is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy children under 5 years old, a move that would add another barrier for parents

13hon MSN

3 Reasons Pfizer's 7%-Yielding Dividend Is Getting Safer

Pfizer (NYSE: PFE) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many ...

mlive on MSN4h

‘Potential exposure’ at Portage Pfizer plant sends people to hospital, MIOSHA investigating

Several workers reported symptoms of being exposed to a substance and some were taken to the hospital. The state is ...

Pfizer looks to expand ADC use after positive bladder cancer data

Padcev, an antibody-drug conjugate which Pfizer acquired via its $43 billion Seagen deal, could help people who don’t qualify ...

1don MSN

Pfizer's combination therapy improves survival in bladder cancer trial

Pfizer said on Tuesday its cancer drug Padcev, in combination with Merck's Keytruda, significantly improved survival rates in ...

Pfizer's Turnaround Has Truly Started (Earnings Update)

Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...

Buy Pfizer Stock At $24?

Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...

2don MSN

Pfizer Just Beat Its Earning Estimates. Is This the Beginning of a Turnaround for the Pharmaceutical Stock?

Pfizer (PFE 0.06%) has been a terrible investment over the past three years. Revenue and earnings have generally moved in the wrong direction, as the company has been unable to fo ...

8don MSN

Pfizer raises 2025 profit forecast as cost-cutting program gains traction

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...

9hon MSN

Should You Now Consider Selling Your Pfizer (PFE) Shares Before its Too Late?

Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results